2014
DOI: 10.1002/uog.14653
|View full text |Cite
|
Sign up to set email alerts
|

Prenatal exome sequencing for fetuses with structural abnormalities: the next step

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
50
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 63 publications
(50 citation statements)
references
References 27 publications
0
50
0
Order By: Relevance
“…Indeed, the relatively high percentage of termination of pregnancy after early detection of anomalies in this study is explained by their severity. Early diagnosis becomes especially important with the introduction of prenatal wide exome sequencing [28,29]. In case of anomalies with normal array comparative genomic hybridization, there is still enough time to carry out this advanced genetic investigation within the legal term for termination in most countries.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, the relatively high percentage of termination of pregnancy after early detection of anomalies in this study is explained by their severity. Early diagnosis becomes especially important with the introduction of prenatal wide exome sequencing [28,29]. In case of anomalies with normal array comparative genomic hybridization, there is still enough time to carry out this advanced genetic investigation within the legal term for termination in most countries.…”
Section: Discussionmentioning
confidence: 99%
“…When uncertain results are found, information may be poorly understood (Hillman et al 2015) and parents often experience distress (Bernhardt et al 2013; Werner-Lin et al 2015). In such cases, even small changes in risk can shape women's risk perception and pregnancy choices (Richards et al 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Early studies performed in pregnancies with ultrasound structural fetal abnormalities have reported conclusive detection rate of 10% in karyotype-and microarray-negative cases (19,20). Targeted mutation testing…”
Section: Genomic Tests In Prenatal Genetic Diagnosismentioning
confidence: 99%